Holtom-Garrett Program in Neuroimmunology and Multiple Sclerosis Center, Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Eur J Immunol. 2013 Nov;43(11):2824-31. doi: 10.1002/eji.201343723. Epub 2013 Aug 23.
In the MOG35-55 induced EAE model, autoreactive Th17 cells that accumulate in the central nervous system acquire Th1 characteristics via a T-bet dependent mechanism. It remains to be determined whether Th17 plasticity and encephalitogenicity are causally related to each other. Here, we show that IL-23 polarized T-bet(-/-) Th17 cells are unimpaired in either activation or proliferation, and induce higher quantities of the chemokines RANTES and CXCL2 than WT Th17 cells. Unlike their WT counterparts, T-bet(-/-) Th17 cells retain an IL-17(hi) IFN-γ(neg-lo) cytokine profile following adoptive transfer into syngeneic hosts. This population of highly polarized Th17 effectors is capable of mediating EAE, albeit with a milder clinical course. It has previously been reported that the signature Th1 and Th17 effector cytokines, IFN-γ and IL-17, are dispensable for the development of autoimmune demyelinating disease. The current study demonstrates that the "master regulator" transcription factor, T-bet, is also not universally required for encephalitogenicity. Our results contribute to a growing body of data showing heterogeneity of myelin-reactive T cells and the independent mechanisms they employ to inflict damage to central nervous system tissues, complicating the search for therapeutic targets relevant across the spectrum of individuals with multiple sclerosis.
在 MOG35-55 诱导的 EAE 模型中,积聚在中枢神经系统中的自身反应性 Th17 细胞通过 T-bet 依赖性机制获得 Th1 特征。Th17 可塑性和致脑炎是否与彼此因果相关仍有待确定。在这里,我们表明,IL-23 极化的 T-bet(-/-)Th17 细胞在激活或增殖方面不受影响,并且诱导比 WT Th17 细胞更高量的趋化因子 RANTES 和 CXCL2。与 WT 细胞不同,T-bet(-/-)Th17 细胞在过继转移到同基因宿主后仍保持 IL-17(hi)IFN-γ(neg-lo)细胞因子谱。这种高度极化的 Th17 效应物能够介导 EAE,尽管临床过程较轻。先前已有报道称,特征性 Th1 和 Th17 效应细胞因子 IFN-γ 和 IL-17 对于自身免疫性脱髓鞘疾病的发展是可有可无的。本研究表明,“主调控”转录因子 T-bet 对于致脑炎也不是普遍必需的。我们的结果有助于越来越多的数据表明髓鞘反应性 T 细胞的异质性以及它们用于对中枢神经系统组织造成损伤的独立机制,这使得寻找与多发性硬化症患者谱相关的治疗靶点变得复杂。